PlainRecalls
FDA Drug Moderate Class II Terminated

Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01

Reported: May 26, 2021 Initiated: April 29, 2021 #D-0390-2021

Product Description

Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01

Reason for Recall

Subpotent Drug

Details

Units Affected
3,138 bottles
Distribution
Nationwide within the United States
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 3,138 bottles.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on May 26, 2021. Severity: Moderate. Recall number: D-0390-2021.